Aberrant recursive splicing in a human disease locus.

Authors

Philip M Boone, Ricardo Harripaul, Rachita Yadav, Michael Grzybowski, Mahmoud K Hanafy, Amanda C Lee, Esther Y Choi, Ryan L Collins, Oksana Polesskaya, Nina Makhortova, Matthew O Larson, Hakan Kayir, Yizhi Wang, Rodolfo A Avila, Jude A Frie, Amr Eed, Abdalla M Albeely, Sunitha Vemuri, Samantha M Ayoub, John M Lemanski, Daniel Ben-Isvy, Xuefang Zhao, Alba Sanchis-Juan, Maris Handley, Serkan Erdin, Celine de Esch, Kiana Mohajeri, Clementine Chen, Paulina Gonzalez Tovar, Monica Salani, Mariana Moyses-Oliveira, Derek J C Tai, Benjamin Currall, Christopher McGraw, Susan Slaugenhaupt, Ryan Doan, Dadi Gao, James F Gusella, Sandra Sanchez-Roige, Jared W Young, Jibran Y Khokhar, Aron M Geurts, Abraham A Palmer, Michael E Talkowski

Published in

Cell reports. Volume 45. Issue 10. Pages 118081. Oct 12, 2026. Epub Oct 12, 2026.

Abstract

Recursive splice sites are rare motifs postulated to facilitate splicing across massive introns and shape isoform diversity. The necessity of recursive splicing (RS) and its role in human disease are unsubstantiated. Here, we use CRISPR to model intronic deletions eliminating an RS site (RS1) in CADM2 and conferring risk for attention deficit hyperactivity disorder and other neurobehavioral traits. Ablating RS1 in human induced neurons alters the gradient of RNA abundance across CADM2's first intron, decreases CADM2 expression, and impacts transcript usage. Decreased CADM2 expression is reflected in reduced exon usage downstream of RS1 and global alteration to genes involved in neuronal processes. In vivo rodent models harboring Cadm2 RS1 deletions exhibit an attenuated effect on Cadm2 expression and modest changes in behavior and functional brain connectivity. This study demonstrates RS as a noncoding regulatory mechanism in a gene associated with a spectrum of neuropsychiatric and behavioral traits.

PMID:
42862720
Bibliographic data and abstract were imported from PubMed on 13 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.